A market forecast has been reported, indicating significant growth in the drug discovery services sector. The predicted value of this market by 2030 is substantial, at $27.23 billion.

This growth is attributed to two main factors. Rising outsourcing is one driver, while expanding research and development pipelines in the biopharma industry is another.

Further details on this market forecast can be found in the Denton Record-Chronicle, providing more information on the projected growth and its implications.